Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/ijn.IJN_167_20 http://scihub22266oqcxt.onion/10.4103/ijn.IJN_167_20 33013061!7470196!33013061     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33013061&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Indian+J+Nephrol 2020 ; 30 (3): 158-160 Nephropedia Template TP {{tp|p=33013061|t=2020. Glomerular Diseases with Reference to COVID-19 |pdf=|usr=}}{{33013061}} gab.com Text Glomerular Diseases with Reference to COVID-19 JO: Indian J Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=33013061 #FOAvip COVID pandemic affected every individual across the world. Patients with primary glomerular disease and glomerular disease secondary to systemic diseases who are on moderate to high doses of immunosuppression are at an increased risk of COVID because of their immunosuppressed state. The data to quantify the degree of risk in relation to the amount of immunosuppression or their duration of use is not robust. The patients on immunosuppression need to modify the drugs balancing the risk relapse and flare of the disease, simultaneously minimizing the risk of developing COVID. We tried to develop a guideline about the modification of the treatment regimen in such conditions. Twit Text FOAVip Glomerular Diseases with Reference to COVID-19 ????Indian J Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=33013061 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33013061 #FOAvip English Wikipedia <ref>{{Cite pmid|33013061}}</ref> Glomerular Diseases with Reference to COVID-19 #MMPMID33013061 Gulati S; Prasad N; Sahay M; Kute V; Agarwal SK Indian J Nephrol 2020[May]; 30 (3): 158-160 PMID33013061show ga COVID pandemic affected every individual across the world. Patients with primary glomerular disease and glomerular disease secondary to systemic diseases who are on moderate to high doses of immunosuppression are at an increased risk of COVID because of their immunosuppressed state. The data to quantify the degree of risk in relation to the amount of immunosuppression or their duration of use is not robust. The patients on immunosuppression need to modify the drugs balancing the risk relapse and flare of the disease, simultaneously minimizing the risk of developing COVID. We tried to develop a guideline about the modification of the treatment regimen in such conditions. ?Glomerular Diseases with Reference to COVID-19 (epmc).pdf DeepDyve Pubget Overpricing